Familial testicular germ cell tumors in adults: 2010 summary of genetic risk factors and clinical phenotype

Endocrine-Related Cancer

Volumn 17, Issue 2, 2010, Pages

  Greene, Mark H ^a   Kratz, Christian P ^a   Mai, Phuong L ^a   Mueller, Christine ^a   Peters, June A ^a   Bratslavsky, Gennady ^a   Ling, Alex ^b   Choyke, Peter M ^a   Premkumar, Ahalya ^b   Bracci, Janet ^c   Watkins, Rissah J ^c   McMaster, Mary Lou ^a   Korde, Larissa A ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c WESTAT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOSOMAL RECESSIVE INHERITANCE; CANCER RISK; CANCER SUSCEPTIBILITY; CHROMOSOME ANALYSIS; CHROMOSOME DELETION Y; FAMILIAL CANCER; FAMILY HISTORY; GENE; GENE LOCUS; GENE MUTATION; GENETIC ASSOCIATION; GENETIC LINKAGE; GENETIC RISK; GERM CELL TUMOR; GROUPS BY AGE; HUMAN; HUMAN GENOME; KIT LIGAND GENE; MALE; MALE INFERTILITY; ONCOGENE C KIT; PENETRANCE; PHENOTYPE; REVIEW; SEMINOMA; SIBLING; TESTIS DEVELOPMENT; TESTIS DISEASE; TESTIS MICROLITHIASIS;

ADULT; AGE OF ONSET; CHROMOSOMES, HUMAN, Y; GENES, NEOPLASM; GENES, TUMOR SUPPRESSOR; GENETIC ASSOCIATION STUDIES; HUMANS; LINKAGE (GENETICS); MALE; NEOPLASMS, GERM CELL AND EMBRYONAL; PEDIGREE; PENETRANCE; RISK FACTORS; SEMINOMA; TESTICULAR NEOPLASMS;

EID: 77953602158     PISSN: 13510088     EISSN: 14796821     Source Type: Journal    
DOI: 10.1677/ERC-09-0254     Document Type: Review

References (77)

1. American Cancer Society 2009 Cancer Facts and Figures 2009. Atlanta: American Cancer Society.
2. Ashman LK 1999 The biology of stem cell factor and its receptor C-kit. International Journal of Biochemistry and Cell Biology 31 1037-1051.
3. van Basten JP, Jonker-Pool G, van Driel MF, Sleijfer DT, Droste JH, van de Wiel HB, Schraffordt Koops H, Molenaar WM & Hoekstra HJ 1997 Sexual functioning after multimodality treatment for disseminated nonseminomatous testicular germ cell tumor. Journal of Urology 158 1411-1416.
4. Berthelsen JG, Skakkebaek NE, von der Maase H, Sorensen BL & Mogensen P 1982 Screening for carcinoma in situ of the contralateral testis in patients with germinal testicular cancer. BMJ 285 1683-1686.
5. Chemes H, Muzulin PM, Venara MC, Mulhmann Mdel C, Martinez M & Gamboni M 2003 Early manifestations of testicular dysgenesis in children: pathological phenotypes, karyotype correlations and precursor stages of tumour development. Acta Pathologica, Microbiologica, et Immunologica Scandinavica 111 12-23.
6. Coffey J, Huddart RA, Elliott F, Sohaib SA, Parker E, Dudakia D, Pugh JL, Easton DF, Bishop DT, Stratton MR et al. 2007 Testicular microlithiasis as a familial risk factor for testicular germ cell tumour. British Journal of Cancer 97 1701-1706.
7. Coffey J, Linger R, Pugh J, Dudakia D, Sokal M, Easton DF, Timothy Bishop D, Stratton M, Huddart R & Rapley EA 2008 Somatic KIT mutations occur predominantly in seminoma germ cell tumors and are not predictive of bilateral disease: report of 220 tumors and review of literature. Genes, Chromosomes & Cancer 47 34-42.
8. Cook MB, Sigurdson AJ, Jones IM, Thomas CB, Graubard BI, Korde L, Greene MH & McGlynn KA 2008 Endogenous DNA damage and testicular germ cell tumors. International Journal of Andrology 32 599-606.
9. Crockford GP, Linger R, Hockley S, Dudakia D, Johnson L, Huddart R, Tucker K, Friedlander M, Phillips KA, Hogg D et al. 2006 Genome-wide linkage screen for testicular germ cell tumour susceptibility loci. Human Molecular Genetics 15 443-451.
10. DeCastro BJ, Peterson AC & Costabile RA 2008 A 5-year followup study of asymptomatic men with testicular microlithiasis. Journal of Urology 179 1420-1423.
11. Dieckmann KP & Loy V 1996 Prevalence of contralateral testicular intraepithelial neoplasia in patients with testicular germ cell neoplasms. Journal of Clinical Oncology 14 3126-3132.
12. Dieckmann KP & Pichlmeier U 1997 The prevalence of familial testicular cancer: an analysis of two patient populations and a review of the literature. Cancer 80 1954-1960.
13. Dong C & Hemminki K 2001 Modification of cancer risks in offspring by sibling and parental cancers from 2,112,616 nuclear families. International Journal of Cancer 92 144-150. (Pubitemid 32187044)
14. Duenas A, Saldivar C, Castillero C, Flores G, Martinez P & Jimenez M 2001 A case of bilateral seminoma in the setting of persistent mullerian duct syndrome. Revista de Investigación Clínica 53 193-196.
15. Giambartolomei C, Mueller CM, Greene MH & Korde LA 2009 A mini-review of familial ovarian germ cell tumors: an additional manifestation of the familial testicular germ cell tumor syndrome. Cancer Epidemiology 33 31-36.
16. Goedert JJ, McKeen EA, Javadpour N, Ozols RF, Pottern LM & Fraumeni JF Jr 1984 Polythelia and testicular cancer. Annals of Internal Medicine 101 646-647.
17. de Gouveia Brazao CA, Pierik FH, Oosterhuis JW, Dohle GR, Looijenga LH & Weber RF 2004 Bilateral testicular microlithiasis predicts the presence of the precursor of testicular germ cell tumors in subfertile men. Journal of Urology 171 158-160.
18. Gu Y, Runyan C, Shoemaker A, Surani A & Wylie C 2009 Steel factor controls primordial germ cell survival and motility from the time of their specification in the allantois, and provides a continuous niche throughout their migration. Development 136 1295-1303.
19. Hardell L, Ohlson CG & Fredrikson M 1997 Occupational exposure to polyvinyl chloride as a risk factor for testicular cancer evaluated in a case-control study. International Journal of Cancer 73 828-830. (Pubitemid 127483035)
20. Heaney JD, Lam MY, Michelson MV & Nadeau JH 2008 Loss of the transmembrane but not the soluble kit ligand isoform increases testicular germ cell tumor susceptibility in mice. Cancer Research 68 5193-5197.
21. Heimdal K, Olsson H, Tretli S, Fossa SD, Borresen AL & Bishop DT 1997 A segregation analysis of testicular cancer based on Norwegian and Swedish families. British Journal of Cancer 75 1084-1087. (Pubitemid 27122631)
22. Hemminki K & Li X 2004 Familial risk in testicular cancer as a clue to a heritable and environmental aetiology. British Journal of Cancer 90 1765-1770.
23. Holmes L Jr, Escalante C, Garrison O, Foldi BX, Ogungbade GO, Essien EJ & Ward D 2008 Testicular cancer incidence trends in the USA (1975-2004): plateau or shifting racial paradigm? Public Health 122 862-872.
24. Horvath A, Boikos S, Giatzakis C, Robinson-White A, Groussin L, Griffin KJ, Stein E, Levine E, Delimpasi G, Hsiao HP et al. 2006 A genome-wide scan identifies mutations in the gene encoding phosphodiesterase 11A4 (PDE11A) in individuals with adrenocortical hyperplasia. Nature Genetics 38 794-800.
25. Horvath A, Korde L, Greene MH, Libe R, Osorio P, Faucz FR, Raffin-Sanson ML, Tsang KM, Drori-Herishanu L, Patronas Y et al. 2009 Functional phosphodiesterase 11A mutations may modify the risk of familial and bilateral testicular germ cell tumors. Cancer Research 69 5301-5306.
26. Huyghe E, Matsuda T & Thonneau P 2003 Increasing incidence of testicular cancer worldwide: a review. Journal of Urology 170 5-11.
27. Hotaling JM & Walsh TJ 2009 Male infertility: a risk factor for testicular cancer. Nature Reviews. Urology 6 550-556.
28. Huddart RA, Norman A, Shahidi M, Horwich A, Coward D, Nicholls J & Dearnaley DP 2003 Cardiovascular disease as a long-term complication of treatment for testicular cancer. Journal of Clinical Oncology 21 1513-1523.
29. Huddart RA, Norman A, Moynihan C, Horwich A, Parker C, Nicholls E & Dearnaley DP 2005 Fertility, gonadal and sexual function in survivors of testicular cancer. British Journal of Cancer 93 200-207.
30. Jacobsen R, Bostofte E, Engholm G, Hansen J, Olsen JH, Skakkebaek NE & Moller H 2000 Risk of testicular cancer in men with abnormal semen characteristics: cohort study. BMJ 321 789-792.
31. Kanetsky PA, Mitra N, Vardhanabhuti S, Li M, Vaughn DJ, Letrero R, Ciosek SL, Doody DR, Smith LM, Weaver J et al. 2009 Common variation in KITLG and at 5q31.3 predisposes to testicular germ cell cancer. Nature Genetics 41 811-815.
32. Kollmannsberger C, Kuzcyk M, Mayer F, Hartmann JT, Kanz L & Bokemeyer C 1999 Late toxicity following curative treatment of testicular cancer. Seminars in Surgical Oncology 17 275-281.
33. Korde LA, Premkumar A, Mueller C, Rosenberg P, Soho C, Bratslavsky G & Greene MH 2008 Increased prevalence of testicular microlithiasis in men with familial testicular cancer and their relatives. British Journal of Cancer 99 1748-1753.
34. Kramer J & Greene MH 2005 Epidemiology of testicular cancer. In Comprehensive Textbook of Genitourinary Oncology, edn 3, pp 558-562. Eds NJ Vogelzang, WU Shipley, PT Scardino & FMJ DeBruyne. Baltimore: Lippincott Williams and Wilkins.
35. Kulkarni JN, Kamat MR & Borges AM 1990 Bilateral synchronous tumors in testes in unrecognized mixed gonadal dysgenesis: a case report and review of literature. Journal of Urology 143 362-364.
36. Leahy MG, Tonks S, Moses JH, Brett AR, Huddart R, Forman D, Oliver RT, Bishop DT & Bodmer JG 1995 Candidate regions for a testicular cancer susceptibility gene. Human Molecular Genetics 4 1551-1555.
37. Lindor NM, McMaster ML, Lindor CJ & Greene MH 2008 Concise Handbook of Familial Cancer Susceptibility Syndromes - Second Edition. Journal of the National Cancer Institute Monographs 38 3-93.
38. Linehan WM, Pinto PA, Bratslavsky G, Pfaffenroth E, Merino M, Vocke CD, Toro JR, Bottaro D, Neckers L, Schmidt LS et al. 2009 Hereditary kidney cancer: unique opportunity for disease-based therapy. Cancer 115 2252-2261.
39. Linger R, Dudakia D, Huddart R, Tucker K, Friedlander M, Phillips KA, Hogg D, Jewett MA, Lohynska R, Daugaard G et al. 2008 Analysis of the DND1 gene in men with sporadic and familial testicular germ cell tumors. Genes, Chromosomes & Cancer 47 247-252.
40. Mai PL, Korde L, Kramer J, Peters J, Mueller CM, Pfeiffer S, Stratakis CA, Pinto PA, Bratslavsky G, Merino M et al. 2007 A possible new syndrome with growth-hormone secreting pituitary adenoma, colonic polyposis, lipomatosis, lentigines and renal carcinoma in association with familial testicular germ cell malignancy: A case report. Journal of Medical Case Reports 1 9.
41. Mai PL, Chen BE, Tucker K, Friedlander M, Phillips KA, Hogg D, Jewett MA, Bodrogi I, Geczi L, Olah E et al. 2009a Younger age-at-diagnosis for familial malignant testicular germ cell tumor. Familial Cancer 8 451-456.
42. Mai PL, Friedlander M, Tucker K, Phillips KA, Hogg D, Jewett MA, Lohynska R, Daugaard G, Richard S, Bonaiti-Pellie C et al. 2009b The International Testicular Cancer Linkage Consortium: a clinicopathologic descriptive analysis of 461 familial malignant testicular germ cell tumor kindred. Urologic Oncology [in press].
43. McCarthy MI, Abecasis GR, Cardon LR, Goldstein DB, Little J, Ioannidis JP & Hirschhorn JN 2008 Genomewide association studies for complex traits: consensus, uncertainty and challenges. Nature Reviews. Genetics 9 356-369.
44. McKiernan JM, Goluboff ET, Liberson GL, Golden R & Fisch H 1999 Rising risk of testicular cancer by birth cohort in the United States from 1973 to 1995. Journal of Urology 162 361-363.
45. Moller H 1998 Trends in sex-ratio, testicular cancer and male reproductive hazards: are they connected? Acta Pathologica, Microbiologica, et Immunologica Scandinavica 106 232-238.
46. Moller H, Prener A & Skakkebaek NE 1996 Testicular cancer, cryptorchidism, inguinal hernia, testicular atrophy, and genital malformations: case-control studies in Denmark. Cancer Causes & Control 7 264-274. (Pubitemid 26156671)
47. Mueller CM, Korde L, Katki HA, Rosenberg PS, Peters JA & Greene MH 2007 Constitutional cytogenetic analysis in men with hereditary testicular germ cell tumor: no evidence of disease-related abnormalities. Cancer Epidemiology, Biomarkers & Prevention 16 2791-2794.
48. Nathanson KL, Kanetsky PA, Hawes R, Vaughn DJ, Letrero R, Tucker K, Friedlander M, Phillips KA, Hogg D, Jewett MA et al. 2005 The Y deletion gr/gr and susceptibility to testicular germ cell tumor. American Journal of Human Genetics 77 1034-1043.
49. Nicholson PW & Harland SJ 1995 Inheritance and testicular cancer. British Journal of Cancer 71 421-426.
50. Nishida T, Hirota S, Taniguchi M, Hashimoto K, Isozaki K, Nakamura H, Kanakura Y, Tanaka T, Takabayashi A, Matsuda H et al. 1998 Familial gastrointestinal stromal tumours with germline mutation of the KIT gene. Nature Genetics 19 323-324. (Pubitemid 28357901)
51. Olsson H, Bladstrom A & Alm P 2002 Male gynecomastia and risk for malignant tumours - a cohort study. BMC Cancer 2 26.
52. Oosterhuis JW & Looijenga LH 2005 Testicular germ-cell tumours in a broader perspective. Nature Reviews. Cancer 5 210-222.
53. Parenti GC, Zago S, Lusa M, Campioni P & Mannella P 2007 Association between testicular microlithiasis and primary malignancy of the testis: our experience and review of the literature. La Radiologia Medica 112 588-596.
54. Pedersini R, Vattemi E, Mazzoleni G & Graiff C 2007 Complete response after treatment with imatinib in pretreated disseminated testicular seminoma with over-expression of c-KIT. Lancet Oncology 8 1039-1040.
55. Peters JA, Vadaparampil ST, Kramer J, Moser RP, Court LJ, Loud J & Greene MH 2006 Familial testicular cancer: interest in genetic testing among high-risk family members. Genetics in Medicine 8 760-770.
56. Peters JA, Beckjord EB, Banda Ryan DR, Carr AG, Vadaparampil ST, Loud JT, Korde L & Greene MH 2008 Testicular cancer and genetics knowledge among familial testicular cancer family members. Journal of Genetic Counseling 17 351-364.
57. Purdue MP, Devesa SS, Sigurdson AJ & McGlynn KA 2005 International patterns and trends in testis cancer incidence. International Journal of Cancer 115 822-827.
58. Rapley EA, Crockford GP, Teare D, Biggs P, Seal S, Barfoot R, Edwards S, Hamoudi R, Heimdal K, Fossa SD et al. 2000 Localization to Xq27 of a susceptibility gene for testicular germ-cell tumours. Nature Genetics 24 197-200.
59. Rapley EA, Crockford GP, Easton DF, Stratton MR & Bishop DT 2003 Localisation of susceptibility genes for familial testicular germ cell tumour. Acta Pathologica, Microbiologica, et Immunologica Scandinavica 111 128-133.
60. Rapley EA, Hockley S, Warren W, Johnson L, Huddart R, Crockford G, Forman D, Leahy MG, Oliver DT, Tucker K et al. 2004 Somatic mutations of KIT in familial testicular germ cell tumours. British Journal of Cancer 90 2397-2401.
61. Rapley EA, Turnbull C, Al Olama AA, Dermitzakis ET, Linger R, Huddart RA, Renwick A, Hughes D, Hines S, Seal S et al. 2009 A genome-wide association study of testicular germ cell tumor. Nature Genetics 41 807-810.
62. Runyan C, Schaible K, Molyneaux K, Wang Z, Levin L & Wylie C 2006 Steel factor controls midline cell death of primordial germ cells and is essential for their normal proliferation and migration. Development 133 4861-4869.
63. SEER 1993 SEER Cancer Statistics Review: 1973-1990, No. 93-2789. Bethesda, Maryland: National Cancer Institute: National Institutes of Health.
64. Skakkebaek NE, Berthelsen JG & Muller J 1982 Carcinoma-in-situ of the undescended testis. Urologic Clinics of North America 9 377-385.
65. Skakkebaek NE, Holm M, Hoei-Hansen C, Jorgensen N & Rajpert-De Meyts E 2003 Association between testicular dysgenesis syndrome (TDS) and testicular neoplasia: evidence from 20 adult patients with signs of maldevelopment of the testis. Acta Pathologica, Microbiologica, et Immunologica Scandinavica 111 1-9.
66. Smyth CM & Bremner WJ 1998 Klinefelter syndrome. Archives of Internal Medicine 158 1309-1314.
67. Swerdlow AJ 1993 The epidemiology of testicular cancer. European Urology 23 35-38.
68. Swerdlow AJ, De Stavola BL, Swanwick MA & Maconochie NE 1997a Risks of breast and testicular cancers in young adult twins in England and Wales: evidence on prenatal and genetic aetiology. Lancet 350 1723-1728.
69. Swerdlow AJ, Higgins CD & Pike MC 1997b Risk of testicular cancer in cohort of boys with cryptorchidism. BMJ 314 1507-1511. (Pubitemid 27216065)
70. Tang X, Boxer M, Drummond A, Ogston P, Hodgins M & Burden AD 2004 A germline mutation in KIT in familial diffuse cutaneous mastocytosis. Journal of Medical Genetics 41 e88.
71. Travis LB, Curtis RE, Storm H, Hall P, Holowaty E, Van Leeuwen FE, Kohler BA, Pukkala E, Lynch CF, Andersson M et al. 1997 Risk of second malignant neoplasms among long-term survivors of testicular cancer. Journal of the National Cancer Institute 89 1429-1439. (Pubitemid 27419206)
72. Vadaparampil ST, Moser RP, Loud J, Peters JA, Greene MH & Korde L 2009 Factors associated with testicular self-examination among unaffected men from multiple-case testicular cancer families. Hereditary Cancer in Clinical Practice 7 11.
73. Walsh TJ, Croughan MS, Schembri M, Chan JM & Turek PJ 2009 Increased risk of testicular germ cell cancer among infertile men. Archives of Internal Medicine 169 351-356.
74. Wanderas EH, Fossa SD & Tretli S 1997 Risk of a second germ cell cancer after treatment of a primary germ cell cancer in 2201 Norwegian male patients. European Journal of Cancer 33 244-252. (Pubitemid 27117722)
75. Wang ZQ, Si L, Tang Q, Lin D, Fu Z, Zhang J, Cui B, Zhu Y, Kong X, Deng M et al. 2009 Gain-of-function mutation of KIT ligand on melanin synthesis causes familial progressive hyperpigmentation. American Journal of Human Genetics 84 672-677.
76. Wayman C, Phillips S, Lunny C, Webb T, Fawcett L, Baxendale R & Burgess G 2005 Phosphodiesterase 11 (PDE11) regulation of spermatozoa physiology. International Journal of Impotence Research 17 216-223.
77. Weir HK, Marrett LD, Kreiger N, Darlington GA & Sugar L 2000 Pre-natal and peri-natal exposures and risk of testicular germ-cell cancer. International Journal of Cancer 87 438-443.